2-(4-Bromo-butoxy)-ethanol | 57343-46-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-(4-Bromo-butoxy)-ethanol
• 英文别名: 2-(4-Bromobutoxy)ethanol
• CAS: 57343-46-1
• 化学式: C₆H₁₃BrO₂
• 分子量: 197.072
• InChiKey: QJERDWPTHRKJRS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  9
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• [EN] SUBSTITUTED 4-AMINO-1-BENZYLPIPERIDINE COMPOUNDS<br/>[FR] COMPOSES DE 4-AMINO-1-BENZYLPIPERIDINE SUBSTITUES
  申请人：THERAVANCE INC

  公开号：WO2005007645A1

  公开（公告）日：2005-01-27

  This invention provides 4-amino-1-benzylpiperidine and related compounds and pharmaceutically acceptable salts thereof which are useful as muscarinic receptor antagonists. This invention also provides pharmaceutical compositions containing such compounds; processes and intermediates useful for preparing such compounds; and methods for treating disease conditions mediated by muscarinic receptors, such as overactive bladder, irritable bowel syndrome, asthma and chronic obstructive pulmonary disease, using such compounds.

  这项发明提供了4-氨基-1-苄基哌啶及其相关化合物和药学上可接受的盐，这些化合物可用作毒蕈碱受体拮抗剂。该发明还提供了含有这些化合物的药物组合物；用于制备这些化合物的有用中间体和过程；以及使用这些化合物治疗由毒蕈碱受体介导的疾病状况的方法，如膀胱过度活跃、肠易激综合征、哮喘和慢性阻塞性肺病。
• Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds
  申请人：——

  公开号：US20040122014A1

  公开（公告）日：2004-06-24

  This invention provides 4-amino-1-(pyridylmethyl)piperidine and related compounds and pharmaceutically acceptable salts thereof which are useful as muscarinic receptor antagonists. This invention also provides pharmaceutical compositions containing such compounds; processes and intermediates useful for preparing such compounds; and methods for treating disease conditions mediated by muscarinic receptors, such as overactive bladder, irritable bowel syndrome and chronic obstructive pulmonary disease, using such compounds.

  本发明提供了4-氨基-1-(吡啶甲基)哌啶及其相关化合物和药物可接受的盐，这些化合物可用作毒蕈碱受体拮抗剂。本发明还提供了含有这些化合物的药物组合物；用于制备这些化合物的工艺和中间体；以及使用这些化合物治疗由毒蕈碱受体介导的疾病状况，如过度活跃的膀胱、肠易激综合征和慢性阻塞性肺疾病的方法。
• Substituted 4-amino-1-benzylpiperidine compounds
  申请人：Mammen Mathai

  公开号：US20050026954A1

  公开（公告）日：2005-02-03

  This invention provides 4-amino-1-benzylpiperidine and related compounds and pharmaceutically acceptable salts thereof which are useful as muscarinic receptor antagonists. This invention also provides pharmaceutical compositions containing such compounds; processes and intermediates useful for preparing such compounds; and methods for treating disease conditions mediated by muscarinic receptors, such as overactive bladder, irritable bowel syndrome, asthma and chronic obstructive pulmonary disease, using such compounds.

  本发明提供了4-氨基-1-苄基哌啶及其相关化合物和药物可接受的盐，其可用作毒蕈碱受体拮抗剂。本发明还提供了含有这种化合物的药物组合物；用于制备这种化合物的有用中间体和过程；以及使用这种化合物治疗由毒蕈碱受体介导的疾病状态，例如过度活跃的膀胱、肠易激综合症、哮喘和慢性阻塞性肺疾病的方法。
• Substituted 4-amino-benzylpiperidine compounds
  申请人：Mammen Mathai

  公开号：US20090023777A1

  公开（公告）日：2009-01-22

  This invention provides 4-amino-1-benzylpiperidine and related compounds and pharmaceutically acceptable salts thereof which are useful as muscarinic receptor antagonists. This invention also provides pharmaceutical compositions containing such compounds; processes and intermediates useful for preparing such compounds; and methods for treating disease conditions mediated by muscarinic receptors, such as overactive bladder, irritable bowel syndrome, asthma and chronic obstructive pulmonary disease, using such compounds.

  本发明提供4-氨基-1-苄基哌啶及其相关化合物和药学上可接受的盐，其作为毒蕈碱受体拮抗剂具有用途。本发明还提供含有这些化合物的制药组合物；用于制备这些化合物的有用中间体和过程；以及使用这些化合物治疗由毒蕈碱受体介导的疾病情况，例如过度活跃的膀胱、肠易激综合征、哮喘和慢性阻塞性肺疾病等的方法。
• SUBSTITUTED 4-AMINO-1-(PYRIDYLMETHYL) PIPERIDINE AS MUSCARINIC RECEPTOR ANTAGONISTS
  申请人：Theravance, Inc.

  公开号：EP1556372A2

  公开（公告）日：2005-07-27